˻ֱ

Skip to main content

Tania de la Fuente, Ph.D.


Department of Health Sciences, Nursing and Public Health
Chemistry


Education

Ph.D., Medicinal Chemistry, Universidad Complutense de Madrid
M.Sc. Chemistry , San Diego State University
B.A. Chemistry, University of San Diego
B.A. Biology, University of San Diego

Practice Areas

  • Medicinal Chemistry
  • Serotonin
  • 5-HT6 receptor

Publications and Media Placements

Queiros, G. W., García, L., de la Fuente, T., Gómez de Salazar, J.M., Criado, A. J. Metallographic Interpretation of the Morphology of the Very Old Pearlite; Archives of Physics ˻ֱ, 2019, 10 (1): 42-51.

ҴDzԳá-ձ&Բ;J. A., Medina R., Martin-Fontecha M., González A., de la Fuente T., Vázquez-Villa H., García-Cárceles J, Botta J., McCormick P. J., Benhamu B., Pardo L., Lopez-Rodriguez M. Scientific Reports, 2017 (7), 41293.

Medina, R.A.; Vázquez-Villa, H M; Gómez-Tamayo, J.C.; Benhamú, B.; Martin-Fontecha, M.; de la Fuente, T; Caltabiano, G; Hedlund, P.B.; Pardo, L.; López-Rodríguez, M.L. Journal of Medicinal Chemistry, 2014, 57(15), 6879-6884.

“Benzimidazole derivatives as new serotonin 5-HT6 receptor antagonists. Molecular mechanisms of receptor inactivation”. Journal of Medicinal. Chemistry, 2010, 53, 1357.

“Benzimidazole derivatives as novel serotonin 5-HT6 receptor antagonists. A computacional and mutagenesis study of ligand-receptor interaction”. Drugs of the Future 2009, 34(Suppl. A), 217 (P161).

“Benzimidazole derivatives as novel serotonin 5-HT6 receptor antagonists. A computacional and mutagenesis study of ligand-receptor interaction”. Drugs of the Future 2008, 33(Suppl. A), 258 (P473).

Benzimidazole derivatives as novel serotonin 5-HT6 receptor ligands”. XV Congreso de la Sociedad Española de Química Terapéutica. El Escorial, 2007

“Design of novel 5-HT6R ligands using pharmacophore and ligand-receptor interaction models”. Lisboa (Portugal), 2007.

“Design of novel 5-HT6R ligands using pharmacophore and ligand-receptor interaction models”. International Symposium on Chemistry, Biology and Medicine. Paphos (Cyprus), 2006.

“A Three-Dimensional Pharmacophore Model for 5-Hydroxytryptamine 6 (5-HT6) Receptor Antagonists”, Journal of Medicinal. Chemistry, 2005, 48, 4219.

“Modelo de Farmacóforo de Antagonistas del Receptor Serotoninérgico 5-HT6.” Congreso: XIV Congreso Nacional Sociedad Española de Química Terapéutica. Bilbao (Leioa), 2005.

“Pharmacophore model and computational simulation for the recognition of serotonin 5-HT6R antagonists. 15th European Symposium on QSAR and Molecular Modelling in Rational Design of Bioactive Molecules”, Istanbul (Turkey). 2004.

“Pharmacophore model and computational simulation for the recognition of 5-HT6R antagonists”. EPHAR 2004-5th Serotonin Symposium. Oporto (Portugal), 2004.

“Asparaginase gene from Aspergillus nidulans”. XXII Fungal Genetics Conference. Asilomar (California), 2003.